M. Worch, V. Wittmann / Carbohydrate Research 343 (2008) 2118–2129
2127
Compound 20: Rf 0.34 (3:1 petroleum ether–EtOAc).
1H NMR (CDCl3, 250 MHz): d 5.99 (d, 1H, J1,2 4.0 Hz,
H-1), 5.32 (m, 1H, H-5), 4.94 (dd, 1H, J2,3 4.93 Hz,
61.75 (C-3b), 55.19 (OMeb). MALDIMS (positive mode,
CHCA, dioxane) m/z calcd for C28H25N3O8: 554.2
[M+Na]+. Found: 554.4. Anal. Calcd: C, 63.27; H,
4.74; N, 7.91. Found: C, 63.13; H, 4.86; N, 7.76.
Compound a-22: Rf 0.38 (4:1 petroleum ether–
EtOAc). H NMR (CDCl3, 250 MHz): d 7.99–8.09 (m,
Pha), 7.38–7.56 (m, Pha), 5.75 (m, H-5a), 5.29 (d, J1,2
4.2 Hz, H-1a), 5.25 (dd, J2,3 4.2, H-2a), 4.82 (dd, J5,6
0
H-2), 4.40 (dd, 1H, J5,6 3.8 Hz, J6;6 12:1 Hz, H-6),
4.17 (dd, 1H, J5;6 6:5 Hz, H-60), 4.11 (dd, 1H, J3,4
0
1
9.6 Hz, J4,5 5.7 Hz, H-4), 3.62 (dd, 1H, H-3), 2.14
(s, 3H, CH3CO), 2.08 (s, 3H, CH3CO), 1.91 (s, 3H,
dioxolane CH3); 13C NMR (CDCl3, 150 MHz): d
170.36 (CO), 169.83 (CO), 116.38 (CN), 104.74
(C-1), 100.84 (dioxolane C), 81.11 (C-2), 76.11 (C-4),
69.97 (C-5), 62.17 (C-6), 61.47 (C-3), 24.31 (dioxolane
CH3), 20.71 (CH3CO), 20.59 (CH3CO). MALDIMS
(positive mode, CHCA, MeCN) m/z calcd for
C13H16N4O7: 363.1 [M+Na]+. Found: 363.1. Anal.
Calcd: C, 45.88; H, 4.74; N, 16.46. Found: C, 45.62;
H, 4.55; N, 16.31.
3.4 Hz, J6,6 12.2, H-6a), 4.69 (dd, J5;6 6:2 Hz, H-60a),
4.55 (dd, J3,4 7.2 Hz, H-3a), 4.46 (t, H-4a), 3.44 (s,
OMea). 13C NMR (CDCl3, 150 MHz): d 128.36—
133.37 (12 C, C-arom.), 100.93 (C-1a), 79.71 (C-4a),
73.02 (C-2a), 71.22 (C-5a), 62.70 (C-6a), 58.87 (C-3a),
55.19 (OMea). MALDIMS (positive mode, CHCA,
dioxane) m/z calcd for C28H25N3O8: 554.2 [M+Na]+.
Found: 554.4.
0
0
Compound 21: Rf 0.34 (3:1 petroleum ether–EtOAc).
1H NMR (CDCl3, 600 MHz): d 6.14 (d, 1H, J1,2
3.8 Hz, H-1), 5.29 (m, 1H, H-5), 5.18 (t, 1H, H-2), 4.41
4.15. 1-O-Acetyl-3-azido-2,5,6-tri-O-benzoyl-3-deoxy-
a,b-D-allofuranose (23)
0
(dd, 1H, J5,6 3.5 Hz, J6;6 12:2 Hz, H-6), 4.19 (dd, 1H,
J5;6 6:1 Hz, H-60), 4.13 (dd, 1H, J3,4 9.5 Hz, J4,5 6.1 Hz,
Compound 22 (2.01 g, 3.78 mmol) was dissolved in
Ac2O (3.55 mL), HOAc (15.12 mL), and concd H2SO4
(990 lL). After 35 min the reaction mixture was poured
on a satd aq NaHCO3 soln. The aq layer was extracted
with CH2Cl2 (3 ꢃ 50 mL). The combined extracts were
dried (MgSO4), concentrated, and the dark brown resi-
due was subjected to column chromatography to yield
23 (1.90 g, 3.40 mmol, 90%) as a colorless oil.
0
H-4), 3.47 (dd, 1H, J2,3 5.1 Hz, H-3), 2.14 (s, 3H,
CH3CO), 2.09 (s, 3H, CH3CO), 1.87 (s, 3H, dioxolane
CH3); 13C NMR (CDCl3, 150 MHz): d 170.44 (CO),
169.93 (CO), 115.59 (CN), 106.11 (C-1), 104.67 (dioxo-
lane C), 83.60 (C-2), 76.40 (C-4), 70.18 (C-5), 62.18
(C-6), 61.86 (C-3), 20.77 (CH3), 20.66 (CH3), 20.63
(CH3). MALDIMS (positive mode, CHCA, MeCN) m/z
calcd for C13H16N4O7: 363.1 [M+Na]+. Found: 363.1.
Compound b-23: Rf 0.38 (4:1 petroleum ether–
1
EtOAc). H NMR (CDCl3, 250 MHz): d 8.07–8.11 (m,
4.14. Methyl 3-azido-2,5,6-tri-O-benzoyl-3-deoxy-a,b-D-
allofuranoside (22)
4H, arom.), 8.00–8.03 (m, 2H, arom.), 7.54–7.63 (m,
3H, arom.), 7.41–7.50 (m, 6H, arom.), 6.34 (s, 1H,
J1,2 < 1 Hz, H-1), 5.76 (m, 1H, H-5), 5.62 (d, 1H, J2,3
0
Compound 15 (948 mg, 4.32 mmol) was dissolved in
pyridine (10 mL) at room temperature. The colorless
soln was cooled in an ice bath and benzoyl chloride
(2.26 mL, 19.44 mmol, 4.5 equiv per OH group) was
added. After stirring for 48 h at room temperature the
soln was concentrated under diminished pressure. The
residue was suspended in EtOAc (100 mL) and washed
with water (100 mL) and sat. NaCl soln (100 mL). The
organic phase was dried (MgSO4) and concentrated.
Chromatographic purification (8:1?5:1 petroleum
ether–EtOAc) afforded 22 (2.05 g, 3.86 mmol, 89%) as
a colorless foam.
4.3 Hz, H-2), 4.79 (dd, 1H, J5,6 3.6 Hz, J6;6 12:1 Hz,
H-6), 4.60 (dd, 1H, J5;6 6:4 Hz, H-60), 4.50–4.56 (m,
0
2H, H-4, H-3), 1.92 (s, 3H, CH3CO). 13C NMR (CDCl3,
150 MHz): d 168.70 (CO), 168.03 (CO), 165.51 (CO),
165.18 (CO), 133.87, 133.64, 133.27, 130.03, 129.89,
129.69, 129.45, 129.15, 128.61, 128.58, 128.50, 128.47
(18 C, C-arom.), 98.21 (C-1), 80.36 (C-4), 76.39 (C-2),
71.81 (C-5), 62.92 (C-6), 61.36 (C-3), 20.67 (CH3).
MALDIMS (positive mode, CHCA, dioxane) m/z calcd
for C29H25N3O9: 582.2 [M+Na]+. Found: 582.4. Anal.
Calcd: C, 62.25; H, 4.50; N, 7.51. Found: C, 62.13; H,
4.70; N, 7.56.
Compound b-22: Rf 0.38 (4:1 petroleum ether–
EtOAc). IR (thin film): m 2113 (N3), 1725 cmꢀ1 (CO).
1H NMR (CDCl3, 250 MHz): d 7.99–8.09 (m, Phb),
7.36–7.65 (m, Phb), 5.75 (m, H-5b), 5.54 (d,
J1,2 < 1 Hz, J2,3 4.7 Hz, H-2b), 5.07 (s, H-1b), 4.88 (dd,
Compound a-23: Rf 0.38 (4:1 petroleum ether–
EtOAc). H NMR (CDCl3, 250 MHz): d 8.01–8.09 (m,
6H, arom.), 7.55–7.64 (m, 3H, arom.), 7.43–7.50 (m,
6H, arom.), 6.57 (s, 1H J1,2 4.4 Hz, H-1), 5.68 (m, 1H,
H-5), 5.45 (dd, 1H, J2,3 7.6 Hz, H-2), 4.76 (dd, 1H, J5,6
1
0
0
0
0
J5,6 3.1 Hz, J6;6 12:1 Hz, H-6b), 4.68 (dd, J5;6 6:3 Hz,
3.9 Hz, J6;6 12:3 Hz, H-6), 4.63 (dd, 1H, J5;6 5:5 Hz,
H-60), 4.58 (t, 1H, J4,5 ꢂ 4.4 Hz, H-4), 4.54 (dd, 1H,
J3,4 4.0 Hz, H-3), 2.14 (s, 3H, CH3CO). 13C NMR
(CDCl3, 150 MHz): d 169.39 (CO), 165.98 (CO), 165.35
(CO), 165.32 (CO), 133.88, 133.70, 133.36, 129.95,
129.83, 129.71, 129.34, 129.02, 128.68, 128.55, 128.43
H-60 ), 4.57 (t, J3,4 ꢂ J4,5 ꢂ 7.6 Hz, H-4b), 4.51 (dd, J2,3
b
4.7 Hz, H-3b), 4.47 (s, OMeb). 13C NMR (CDCl3,
150 MHz): d 165.74 (COb), 165.37 (COb), 164.98
(COb), 128.36–134.26 (12 C, C-arom.), 106.11 (C-1b),
78.76 (C-4b), 76.61 (C-2b), 72.33 (C-5b), 62.93 (C-6b),